|
US4709017A
(en)
|
1985-06-07 |
1987-11-24 |
President And Fellows Of Harvard College |
Modified toxic vaccines
|
|
US4950740A
(en)
|
1987-03-17 |
1990-08-21 |
Cetus Corporation |
Recombinant diphtheria vaccines
|
|
US4912094B1
(en)
|
1988-06-29 |
1994-02-15 |
Ribi Immunochem Research Inc. |
Modified lipopolysaccharides and process of preparation
|
|
NZ230747A
(en)
|
1988-09-30 |
1992-05-26 |
Bror Morein |
Immunomodulating matrix comprising a complex of at least one lipid and at least one saponin; certain glycosylated triterpenoid saponins derived from quillaja saponaria molina
|
|
DE3841091A1
(en)
|
1988-12-07 |
1990-06-13 |
Behringwerke Ag |
SYNTHETIC ANTIGENS, METHOD FOR THEIR PRODUCTION AND THEIR USE
|
|
CA2006700A1
(en)
|
1989-01-17 |
1990-07-17 |
Antonello Pessi |
Synthetic peptides and their use as universal carriers for the preparation of immunogenic conjugates suitable for the development of synthetic vaccines
|
|
AU651949B2
(en)
|
1989-07-14 |
1994-08-11 |
American Cyanamid Company |
Cytokine and hormone carriers for conjugate vaccines
|
|
DE69016129T2
(en)
|
1989-08-18 |
1995-05-24 |
Akzo Nobel Nv |
Vaccine against Escherichia coli.
|
|
IT1237764B
(en)
|
1989-11-10 |
1993-06-17 |
Eniricerche Spa |
SYNTHETIC PEPTIDES USEFUL AS UNIVERSAL CARRIERS FOR THE PREPARATION OF IMMUNOGENIC CONJUGATES AND THEIR USE FOR THE DEVELOPMENT OF SYNTHETIC VACCINES.
|
|
SE466259B
(en)
|
1990-05-31 |
1992-01-20 |
Arne Forsgren |
PROTEIN D - AN IGD BINDING PROTEIN FROM HAEMOPHILUS INFLUENZAE, AND THE USE OF THIS FOR ANALYSIS, VACCINES AND PURPOSE
|
|
ATE128628T1
(en)
|
1990-08-13 |
1995-10-15 |
American Cyanamid Co |
FIBER HEMAGGLUTININ FROM BORDETELLA PERTUSSIS AS A CARRIER FOR CONJUGATE VACCINE.
|
|
US5370872A
(en)
*
|
1991-08-12 |
1994-12-06 |
Swiss Serum And Vaccine Institute Berne |
Escherichia coliO-polysaccharide-protein conjugate vaccine
|
|
IT1262896B
(en)
|
1992-03-06 |
1996-07-22 |
|
CONJUGATE COMPOUNDS FORMED FROM HEAT SHOCK PROTEIN (HSP) AND OLIGO-POLY-SACCHARIDES, THEIR USE FOR THE PRODUCTION OF VACCINES.
|
|
JP3506431B2
(en)
|
1992-05-06 |
2004-03-15 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Diphtheria toxin receptor binding domain
|
|
US5340740A
(en)
|
1992-05-15 |
1994-08-23 |
North Carolina State University |
Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
|
|
DE69313134T2
(en)
|
1992-06-25 |
1998-02-26 |
Smithkline Beecham Biolog |
VACCINE COMPOSITION CONTAINING ADJUVANTIES
|
|
IL102687A
(en)
|
1992-07-30 |
1997-06-10 |
Yeda Res & Dev |
Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
|
|
DK0616034T3
(en)
|
1993-03-05 |
2005-02-21 |
Wyeth Corp |
Plasmid for the preparation of CRM protein and diphtheria toxin
|
|
KR100310510B1
(en)
|
1993-03-23 |
2002-07-04 |
장 스테판느 |
Vaccine composition containing 3-0-deacetylated monophosphoryl lipid A
|
|
GB9326253D0
(en)
|
1993-12-23 |
1994-02-23 |
Smithkline Beecham Biolog |
Vaccines
|
|
US5917017A
(en)
|
1994-06-08 |
1999-06-29 |
President And Fellows Of Harvard College |
Diphtheria toxin vaccines bearing a mutated R domain
|
|
US6455673B1
(en)
|
1994-06-08 |
2002-09-24 |
President And Fellows Of Harvard College |
Multi-mutant diphtheria toxin vaccines
|
|
US6239116B1
(en)
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
AU713040B2
(en)
|
1994-07-15 |
1999-11-18 |
University Of Iowa Research Foundation, The |
Immunomodulatory oligonucleotides
|
|
AUPM873294A0
(en)
|
1994-10-12 |
1994-11-03 |
Csl Limited |
Saponin preparations and use thereof in iscoms
|
|
FR2726003B1
(en)
|
1994-10-21 |
2002-10-18 |
Agronomique Inst Nat Rech |
CULTURE MEDIUM OF AVIAN TOTIPOTENT EMBRYONIC CELLS, METHOD FOR CULTURING THESE CELLS, AND AVIAN TOTIPOTENT EMBRYONIC CELLS
|
|
GB9513261D0
(en)
|
1995-06-29 |
1995-09-06 |
Smithkline Beecham Biolog |
Vaccines
|
|
AUPO517897A0
(en)
|
1997-02-19 |
1997-04-11 |
Csl Limited |
Chelating immunostimulating complexes
|
|
CA2281838A1
(en)
|
1997-02-28 |
1998-09-03 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders
|
|
US6749831B1
(en)
|
1997-05-16 |
2004-06-15 |
Medical Defense Technology, Llc |
Vaccine against lipopolysaccharide core
|
|
EP1003531B1
(en)
|
1997-05-20 |
2007-08-22 |
Ottawa Health Research Institute |
Processes for preparing nucleic acid constructs
|
|
GB9712347D0
(en)
|
1997-06-14 |
1997-08-13 |
Smithkline Beecham Biolog |
Vaccine
|
|
GB9713156D0
(en)
|
1997-06-20 |
1997-08-27 |
Microbiological Res Authority |
Vaccines
|
|
EP1279401B1
(en)
|
1997-09-05 |
2008-01-09 |
GlaxoSmithKline Biologicals S.A. |
Oil in water emulsions containing saponins
|
|
US6303114B1
(en)
|
1998-03-05 |
2001-10-16 |
The Medical College Of Ohio |
IL-12 enhancement of immune responses to T-independent antigens
|
|
US6218371B1
(en)
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
BR9909915A
(en)
|
1998-04-09 |
2000-12-26 |
Smithkline Beecham Biolog |
Adjuvant compositions
|
|
US6858211B1
(en)
|
1998-07-20 |
2005-02-22 |
The United States Of America As Represented By The Department Of Health And Human Services |
Vaccines against Escherichia coli O157 infection
|
|
CA2338093C
(en)
|
1998-07-20 |
2010-11-30 |
Shousun C. Szu |
Vaccines against escherichia coli o157 infection
|
|
GB9817052D0
(en)
|
1998-08-05 |
1998-09-30 |
Smithkline Beecham Biolog |
Vaccine
|
|
ES2284287T3
(en)
|
1998-10-16 |
2007-11-01 |
Glaxosmithkline Biologicals S.A. |
ADJUSTMENT SYSTEMS AND VACCINES.
|
|
CA2355364C
(en)
|
1998-12-21 |
2014-03-18 |
Medimmune, Inc. |
Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
|
|
PL205041B1
(en)
|
1998-12-23 |
2010-03-31 |
Id Biomedical Corp |
Isolated polynucleotide, vector comprising isolated polynucleotide, vector transformed or transfected host cell, method for production of isolated polypeptide coded by isolated polynucleotide, isolated polypeptide, chimeric polypeptide, composition for vaccines and its use in treating streptococcus infection
|
|
AUPP807399A0
(en)
|
1999-01-08 |
1999-02-04 |
Csl Limited |
Improved immunogenic lhrh composition and methods relating thereto
|
|
DE60044236D1
(en)
|
1999-02-17 |
2010-06-02 |
Csl Ltd |
IMMUNOGENIC COMPLEXES AND METHODS RELATED TO THEM
|
|
CA2366152A1
(en)
|
1999-03-19 |
2000-09-28 |
Smithkline Beecham Biologicals S.A. |
Streptococcus pneumoniae vaccine
|
|
WO2000061761A2
(en)
|
1999-04-09 |
2000-10-19 |
Techlab, Inc. |
Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
|
|
DK1187629T3
(en)
|
1999-04-19 |
2005-01-17 |
Glaxosmithkline Biolog Sa |
Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
|
|
HK1045713A1
(en)
|
1999-07-13 |
2002-12-06 |
Medimmune, Inc. |
Donor strand complemented pilin and adhesin broad-based vaccines
|
|
IL148671A0
(en)
|
1999-09-24 |
2002-09-12 |
Smithkline Beecham Biolog |
Adjuvant comprising a polyxyethylene alkyl ether or ester and at least one nonionic surfactant
|
|
HK1049106A1
(en)
|
1999-09-24 |
2003-05-02 |
Smithkline Beecham Biologicals S.A. |
Use of the combination of polyoxyethylene sorbitan ester and octoxynol as adjuvant and its use in vaccines
|
|
GB0007432D0
(en)
|
2000-03-27 |
2000-05-17 |
Microbiological Res Authority |
Proteins for use as carriers in conjugate vaccines
|
|
WO2001098334A2
(en)
|
2000-06-20 |
2001-12-27 |
Shire Biochem Inc. |
Streptococcus antigens
|
|
AU2001271907A1
(en)
|
2000-07-07 |
2002-01-21 |
Medimmune, Inc. |
FimH adhesin proteins and methods of use
|
|
AU2002218927B2
(en)
|
2001-01-04 |
2007-08-30 |
The University Of British Columbia |
Enterohemorrhagic Escherichia coli vaccine
|
|
AU2002309706A1
(en)
|
2001-05-11 |
2002-11-25 |
Aventis Pasteur, Inc. |
Novel meningitis conjugate vaccine
|
|
US7262024B2
(en)
|
2001-12-20 |
2007-08-28 |
Id Biomedical Corporation |
Streptococcus antigens
|
|
MXPA05009579A
(en)
|
2003-03-13 |
2005-11-17 |
Glaxosmithkline Biolog Sa |
Purification process for bacterial cytolysin.
|
|
EP1603950A2
(en)
|
2003-03-17 |
2005-12-14 |
Wyeth Holdings Corporation |
Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
|
|
JP2008506789A
(en)
|
2004-07-18 |
2008-03-06 |
シーエスエル、リミテッド |
Immunostimulatory complex and oligonucleotide formulation for inducing enhanced interferon-gamma response
|
|
EP1776105A2
(en)
|
2004-07-18 |
2007-04-25 |
Coley Pharmaceutical Group, Ltd |
Methods and compositions for inducing innate immune responses
|
|
EP1789454B1
(en)
*
|
2004-08-12 |
2017-07-05 |
Lipoxen Technologies Limited |
Fractionation of charged polysaccharide
|
|
GB0421083D0
(en)
|
2004-09-22 |
2004-10-27 |
Glaxosmithkline Biolog Sa |
Purification process
|
|
US7709001B2
(en)
|
2005-04-08 |
2010-05-04 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
IL308456A
(en)
|
2005-04-08 |
2024-01-01 |
Wyeth Llc |
Multivalent pneumococcal polysacharide-protein conjugate composition
|
|
US7955605B2
(en)
|
2005-04-08 |
2011-06-07 |
Wyeth Llc |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
US20070184072A1
(en)
|
2005-04-08 |
2007-08-09 |
Wyeth |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
|
TW200806315A
(en)
|
2006-04-26 |
2008-02-01 |
Wyeth Corp |
Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
|
|
US20100251416A1
(en)
|
2007-05-22 |
2010-09-30 |
Basf Plant Science Gmbh |
Plants with increased tolerance and/or resistance to environmental stress and increased biomass production
|
|
EA200901578A1
(en)
|
2007-06-26 |
2010-08-30 |
Глаксосмитклайн Байолоджикалс С.А. |
VACCINE CONTAINING CONJUGATES OF CAPSULAR POLYSACCHARIDES STREPTOCOCCUS PNEUMONIAE
|
|
DK2424562T3
(en)
|
2009-04-30 |
2015-12-07 |
Coley Pharm Group Inc |
Pneumococcal vaccine and uses thereof
|
|
AU2010264538B2
(en)
*
|
2009-06-22 |
2013-10-03 |
Wyeth Llc |
Immunogenic compositions of Staphylococcus aureus antigens
|
|
WO2011041003A2
(en)
|
2009-06-22 |
2011-04-07 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
CA2768343A1
(en)
|
2009-07-16 |
2011-01-20 |
Novartis Ag |
Detoxified escherichia coli immunogens
|
|
PT2493498T
(en)
|
2009-10-30 |
2017-05-24 |
Glaxosmithkline Biologicals Sa |
Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
|
|
WO2011138361A1
(en)
|
2010-05-06 |
2011-11-10 |
Glycovaxyn |
Capsular gram-positive bacteria bioconjugate vaccines
|
|
WO2012001004A1
(en)
|
2010-07-02 |
2012-01-05 |
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. |
Fimh vaccine against urinary tract infections (uti)
|
|
WO2013164334A1
(en)
|
2012-05-04 |
2013-11-07 |
Universiteit Gent |
Escherichia coli vaccine
|
|
DK2859013T3
(en)
|
2012-06-12 |
2016-12-19 |
Fina Biosolutions Llc |
DIFFERENTIAL functionalization of polymers having AMINO-OXY reagents for diagnostic assays
|
|
CA2879272A1
(en)
|
2012-07-16 |
2014-01-23 |
Robert G.K. DONALD |
Saccharides and uses thereof
|
|
PT2885007T
(en)
*
|
2012-08-16 |
2018-12-10 |
Pfizer |
Glycoconjugation processes and compositions
|
|
KR20150068998A
(en)
|
2012-10-12 |
2015-06-22 |
글리코박신 아게 |
Methods of host cell modification
|
|
EP2917351B1
(en)
|
2012-11-07 |
2018-12-19 |
GlaxoSmithKline Biologicals S.A. |
Production of recombinant vaccine in e. coli by enzymatic conjugation
|
|
RU2672053C2
(en)
|
2012-12-20 |
2018-11-09 |
Пфайзер Инк. |
Glycoconjugation process
|
|
HUE038915T2
(en)
|
2013-01-17 |
2018-12-28 |
Arsanis Biosciences Gmbh |
Mdr e. coli specific antibody
|
|
WO2015010185A1
(en)
|
2013-07-26 |
2015-01-29 |
University Of Saskatchewan |
Methods for producing salmonella o- antigen capsules, compositions and uses thereof
|
|
US9415101B2
(en)
|
2013-09-25 |
2016-08-16 |
Sequoia Sciences, Inc. |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
US9504743B2
(en)
|
2013-09-25 |
2016-11-29 |
Sequoia Sciences, Inc |
Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections
|
|
BR112016007727A8
(en)
|
2013-10-11 |
2018-01-30 |
Glycovaxyn Ag |
host cell, and method for producing an unglycosylated protein.
|
|
IL312327B2
(en)
|
2014-01-21 |
2026-02-01 |
Pfizer |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
NZ723328A
(en)
|
2014-02-24 |
2018-01-26 |
Glycovaxyn Ag |
Compositions comprising e. coli o25b antigen, uses thereof and methods of manufacture
|
|
CN106659799B
(en)
|
2014-07-25 |
2020-07-17 |
碧奥辛斯有限责任公司 |
Glycoconjugate vaccines comprising a basic unit of a molecular construct expressing a built-in plurality of epitopes for the preparation of a broad spectrum vaccine against infections caused by enteropathogenic bacteria
|
|
US20160015797A1
(en)
|
2014-08-06 |
2016-01-21 |
Pasteur Institute of Iran (IPI) |
VACCINE FOR UTI WITH TRUNCATED FORM OF FLAGELLIN (FliC) FROM ENTEROAGGREGATIVE ESCHERICHIA COLI FUSED WITH FimH PROTEIN
|
|
US9988426B2
(en)
|
2014-09-18 |
2018-06-05 |
University Of Maryland, Baltimore |
Broad spectrum conjugate vaccine to prevent Klebsiella pneumoniae and Pseudomonas aeruginosa infections
|
|
US9814769B2
(en)
|
2014-09-30 |
2017-11-14 |
Qatar University |
Vaccines against pathogenic Escherichia coli and methods of using the same
|
|
WO2016115328A1
(en)
|
2015-01-14 |
2016-07-21 |
Washington University |
Vaccine compositions for use against enterotoxigenic escherichia coli
|
|
WO2016168324A1
(en)
|
2015-04-13 |
2016-10-20 |
University Of Maryland, Baltimore |
Compositions and methods for producing bacterial conjugate vaccines
|
|
KR102143534B1
(en)
|
2015-05-04 |
2020-08-12 |
화이자 인코포레이티드 |
Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
|
|
US10722580B2
(en)
|
2015-05-13 |
2020-07-28 |
University Of Washington |
Compositions and methods for treatment and prevention of uropathogenic E. coli infection
|
|
TWI715617B
(en)
|
2015-08-24 |
2021-01-11 |
比利時商葛蘭素史密斯克藍生物品公司 |
Methods and compositions for immune protection against extra-intestinal pathogenic e. coli
|
|
US10786561B2
(en)
|
2015-11-20 |
2020-09-29 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
CN119242587A
(en)
|
2017-02-17 |
2025-01-03 |
隆萨有限公司 |
Multisite-specific integration of difficult-to-express proteins into cells
|
|
GB201711635D0
(en)
|
2017-07-19 |
2017-08-30 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition
|
|
TW201946650A
(en)
|
2018-03-12 |
2019-12-16 |
美商詹森藥物公司 |
Vaccines against intra-abdominal infections
|
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
AU2020375214B2
(en)
|
2019-11-01 |
2024-02-08 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
MY209568A
(en)
|
2020-01-16 |
2025-07-22 |
Janssen Pharmaceuticals Inc |
Fimh mutant, compositions therewith and use thereof
|
|
KR20220143910A
(en)
|
2020-02-23 |
2022-10-25 |
화이자 인코포레이티드 |
Escherichia coli composition and method thereof
|
|
MX2023004912A
(en)
|
2020-10-27 |
2023-05-16 |
Pfizer |
Compositions and methods thereof.
|
|
US12138302B2
(en)
|
2020-10-27 |
2024-11-12 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
US12357681B2
(en)
|
2020-12-23 |
2025-07-15 |
Pfizer Inc. |
E. coli FimH mutants and uses thereof
|